Recent 8-K filings for SHC

Each filing is summarized by an LLM — headline, three bullets, event type. The source document on EDGAR is one click away. See methodology.

• May 13, 2026 20:11 UTC other_material item 1.02item 8.01item 9.01

  Sponsors Warburg Pincus and GTCR exit Sotera Health via secondary offering; Stockholders Agreement terminated.

• May 05, 2026 23:59 UTC earnings item 2.02item 5.02item 9.01

  Sotera Health reports Q1 2026 results and announces CEO transition

• Mar 16, 2026 23:59 UTC leadership item 5.02

  Director Constantine S. Mihas resigns; Kenneth D. Krause appointed to board

• Mar 06, 2026 23:59 UTC other_material item 8.01item 9.01

  Sotera Health selling stockholders launch 25M-share secondary offering at $15.27 each

• Feb 24, 2026 23:59 UTC earnings item 2.02item 5.02item 9.01

  Sotera Health reports 2025 record revenue up 5.7% to $1.164B; guided 2026 growth 5-6.5%

• Feb 05, 2026 23:59 UTC leadership item 5.02

  Sotera Health appoints Richard G. Kyle to Board of Directors as Class III director

• Jan 12, 2026 23:59 UTC earnings item 2.02item 7.01item 9.01

  Sotera Health expects FY2025 revenue >$1.16B, up at least 5.5% YoY

• Nov 10, 2025 23:59 UTC other_material item 8.01item 9.01

  Sotera Health selling stockholders to sell 30M shares at $15.651 each

• Nov 04, 2025 23:59 UTC earnings item 2.02item 9.01

  Sotera Health Q3 net revenues +9.1% to $311M; adj EBITDA +12.2%; raises 2025 guidance

• Sep 18, 2025 23:59 UTC debt item 1.01item 2.03item 9.01

  Sotera Health refinances $1.423B term loans, cuts interest margin by 0.50%

• Sep 05, 2025 23:59 UTC other_material item 8.01item 9.01

  Sotera Health selling stockholders sell 20M shares in secondary offering at $15.111/share

• Aug 08, 2025 23:59 UTC earnings item 2.02item 9.01

  Sotera Health Q2 revenue up 6.4% to $294M; Adj EBITDA +9.8% to $151M; raises FY outlook

• Jul 24, 2025 23:59 UTC litigation item 7.01

  Sotera Health subsidiary Sterigenics settles 129 EO claims for $34M

source · SHC on sec.gov